|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 07-16 | Truist Securities Adjusts Price Target on Vericel to $54 From $42, Maintains Buy Rating | MT |
| 05-07 | Vericel Corporation, Q1 2026 Earnings Call, May 07, 2026 |
| Market Cap | 2.44B 2.13B 1.97B 1.81B 3.43B 235B 3.49B 23.54B 9.25B 115B 9.17B 8.97B 397B | P/E 2026 * |
101x | P/E 2027 * | 54.6x |
|---|---|---|---|---|---|
| Enterprise Value | 2.44B 2.13B 1.97B 1.81B 3.43B 235B 3.49B 23.54B 9.25B 115B 9.17B 8.97B 397B | EV / Sales 2026 * |
7.35x | EV / Sales 2027 * | 6.28x |
| Free-Float |
98.81% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Aastrom Biosciences Inc
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 2013-02-28 | |
Joseph Mara
DFI | Director of Finance/CFO | 51 | 2021-01-24 |
| Chief Tech/Sci/R&D Officer | - | 2023-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Rubino
BRD | Director/Board Member | 71 | 2005-09-27 |
Robert Zerbe
CHM | Chairman | 75 | 2012-10-04 |
Heidi Hagen
BRD | Director/Board Member | 57 | 2013-08-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.18% | +1.65% | +23.91% | -5.51% | 69.07B | |
| +0.85% | -4.92% | +40.11% | +199.67% | 51.77B | |
| +0.94% | +39.60% | +39.60% | +39.60% | 43.63B | |
| +0.90% | +0.13% | -50.46% | -52.46% | 40.89B | |
| +5.92% | +5.03% | +62.63% | -25.10% | 30.84B | |
| -7.51% | -17.52% | +96.97% | -47.96% | 25.06B | |
| +1.36% | -1.58% | +68.50% | +88.88% | 23.3B | |
| -5.79% | -1.06% | -0.39% | +181.75% | 20.92B | |
| +2.15% | -2.72% | +64.59% | +129.01% | 16.71B | |
| Average | +0.11% | -1.56% | +38.39% | +56.43% | 35.8B | |
| Weighted average by Cap. | +0.66% | -1.35% | +32.35% | +48.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 332M 290M 269M 246M 466M 32.01B 474M 3.2B 1.26B 15.63B 1.25B 1.22B 53.97B | 389M 340M 314M 288M 546M 37.45B 555M 3.75B 1.47B 18.29B 1.46B 1.43B 63.14B |
| Net income | 24.64M 21.53M 19.92M 18.27M 34.59M 2.37B 35.19M 238M 93.3M 1.16B 92.52M 90.49M 4B | 46.35M 40.52M 37.47M 34.38M 65.07M 4.47B 66.2M 447M 176M 2.18B 174M 170M 7.53B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
